Abstract
Glucagon-like Peptide 1 Receptor Agonists, Heart Failure, and Critical Appraisal: How the STEP-HFpEF Trial Unmasks the Need for Improved Reporting of Blinding
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have